These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8279756)

  • 1. Clinical relevance of cell kinetics in breast cancer.
    Amadori D; Volpi A; Callea A; Amaducci L; Morgagni S; Magni E; Nanni O
    Ann N Y Acad Sci; 1993 Nov; 698():186-92. PubMed ID: 8279756
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptors as prognostic factors in early breast cancer.
    Saez S; Cheix F; Mayer M
    Recent Results Cancer Res; 1984; 91():192-8. PubMed ID: 6729216
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).
    Kataja VV; Colleoni M; Bergh J;
    Ann Oncol; 2005; 16 Suppl 1():i10-2. PubMed ID: 15888735
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients.
    Pronzato P; Bertelli G; Gardin G; Rubagotti A; Conte PF; Rosso R
    Oncology; 1993; 50(6):460-5. PubMed ID: 8233288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
    Bianco AR; De Placido S; Perrone F; Carlomagno C; De Laurentiis M; Del Mastro L; Lauria R; Marinelli A; Gallo C
    Ann N Y Acad Sci; 1993 Nov; 698():330-8. PubMed ID: 8279772
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
    Harbeck N; Untch M; Pache L; Eiermann W
    Br J Cancer; 1994 Mar; 69(3):566-71. PubMed ID: 7510120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study.
    Spyratos F; Martin PM; Hacène K; Andrieu C; Romain S; Floiras JL; Magdelénat H
    Breast Cancer Res Treat; 1994 Jan; 29(1):85-95. PubMed ID: 8018965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of epithelial expression of progesterone receptor in breast cancers with marked fibrosis and limited metastatic node diffusion.
    Giani C; Campani D; De Negri F; Gigliotti A; Fabbri R; Bonacci R; Fierabracci P; Mammoli C; Squartini F; Pinchera A
    Ann N Y Acad Sci; 1993 Nov; 698():148-52. PubMed ID: 8279753
    [No Abstract]   [Full Text] [Related]  

  • 11. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-p-hydroxyphenyllactate-esterase activity in breast cancer: a potentially new prognostic factor in short-term follow-up.
    Carbone A; Serra FG; Ferrandina G; Scambia G; Terribile D; Bellantone R; Piantelli M; Ranelletti FO
    Cancer Res; 1997 Dec; 57(23):5406-9. PubMed ID: 9393767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study.
    Kim SJ; Shiba E; Ishii H; Inoue T; Taguchi T; Tanji Y; Kimoto Y; Izukura M; Takai S
    Anticancer Res; 1997; 17(3C):2319-23. PubMed ID: 9216709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of women with node negative breast cancer in the Auckland region.
    Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
    N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of adequate staging and of hormone receptors in women older than age 70 with breast cancer.
    Gazetas P; Estabrook A; O'Neil J; Sciacca R
    Ann Surg; 1992 Jul; 216(1):22-6. PubMed ID: 1632698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Shimazu K; Ueda S; Yanagisawa T; Okishiro N; Imazato M; Yasuyuki K; Sato Y; Tamura S; Noguchi S
    Breast J; 2008; 14(6):523-31. PubMed ID: 19000056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
    Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
    J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.
    Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F
    Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
    Graeff H; Jänicke F
    Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.